In the field of lung transplantation, we reported a persistently low level of CD9+ B cells in patients with chronic lung allograft dysfunction; conversely, patients able to restore a higher level of CD9+ B cells posttransplantation were more likely to maintain stable graft function. This evidence concerns the gene CD9 and chronic lung allograft dysfunction.